
During a live event, Rushang Patel, MD, PhD, and participants discussed referral timing, bridging, and payer barriers that shape access to cellular therapy in early relapsed multiple myeloma.
Relapsed/Refractory Multiple Myeloma
Case: 75-Year-Old Man With Symptomatic R/R Multiple Myeloma
January 2015
September 2018